Exosome-Based Neurodegenerative Disease Therapeutics Market Growth, Company Revenue Share, Key Drivers & Trend Analysis By FMI
NEWARK, DE | The Exosome-Based Neurodegenerative Disease Therapeutics Market, valued at USD 25.9 million in 2025, is projected to reach USD 32.8 million in 2026 and expand rapidly to USD 352.5 million by 2036, registering a CAGR of 26.80% during the forecast period. This growth reflects a structural shift in neurology drug development, as traditional small molecules fail to cross the...
0 Commenti 0 Condivisioni 37 Visualizzazioni